302 related articles for article (PubMed ID: 30580667)
1. An Observational Study of the Efficacy and Safety of Voriconazole in a Real-Life Clinical Setting.
Blanco-Dorado S; Cea-Arestin C; González Carballo A; Latorre-Pellicer A; Maroñas Amigo O; Barbeito Castiñeiras G; Pérez Del Molino Bernal ML; Campos-Toimil M; Fernández-Ferreiro A; Lamas MJ
J Chemother; 2019 Feb; 31(1):49-57. PubMed ID: 30580667
[TBL] [Abstract][Full Text] [Related]
2. Effect of proton pump inhibitor on plasma voriconazole concentration in Thai patients.
Chayakulkeeree M; Poovipirom N; Siengwattana P; Maneerattanaporn M
J Med Assoc Thai; 2015 Mar; 98(3):232-7. PubMed ID: 25920292
[TBL] [Abstract][Full Text] [Related]
3. Voriconazole: How to Use This Antifungal Agent and What to Expect.
Malani AN; Kerr LE; Kauffman CA
Semin Respir Crit Care Med; 2015 Oct; 36(5):786-95. PubMed ID: 26398543
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections.
Wang T; Xie J; Wang Y; Zheng X; Lei J; Wang X; Dong H; Yang Q; Chen L; Xing J; Dong Y
Pharmacotherapy; 2015 Sep; 35(9):797-804. PubMed ID: 26406771
[TBL] [Abstract][Full Text] [Related]
5. Worsening pneumonitis due to a pharmacokinetic drug-drug interaction between everolimus and voriconazole in a renal transplant patient.
Lecefel C; Eloy P; Chauvin B; Wyplosz B; Amilien V; Massias L; Taburet AM; Francois H; Furlan V
J Clin Pharm Ther; 2015 Feb; 40(1):119-20. PubMed ID: 25417855
[TBL] [Abstract][Full Text] [Related]
6. Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.
Pascual A; Calandra T; Bolay S; Buclin T; Bille J; Marchetti O
Clin Infect Dis; 2008 Jan; 46(2):201-11. PubMed ID: 18171251
[TBL] [Abstract][Full Text] [Related]
7. CYP2C19 Genotype-Dependent Pharmacokinetic Drug Interaction Between Voriconazole and Ritonavir-Boosted Atazanavir in Healthy Subjects.
Zhu L; Brüggemann RJ; Uy J; Colbers A; Hruska MW; Chung E; Sims K; Vakkalagadda B; Xu X; van Schaik RH; Burger DM; Bertz RJ
J Clin Pharmacol; 2017 Feb; 57(2):235-246. PubMed ID: 27432796
[TBL] [Abstract][Full Text] [Related]
8. Inflammation is a potential risk factor of voriconazole overdose in hematological patients.
Gautier-Veyret E; Truffot A; Bailly S; Fonrose X; Thiebaut-Bertrand A; Tonini J; Cahn JY; Stanke-Labesque F
Fundam Clin Pharmacol; 2019 Apr; 33(2):232-238. PubMed ID: 30306637
[TBL] [Abstract][Full Text] [Related]
9. A retrospective, multicenter study of voriconazole trough concentrations and safety in patients with Child-Pugh class C cirrhosis.
Wang T; Yan M; Tang D; Xue L; Zhang T; Dong Y; Zhu L; Wang X; Dong Y
J Clin Pharm Ther; 2018 Dec; 43(6):849-854. PubMed ID: 29893015
[TBL] [Abstract][Full Text] [Related]
10. PHARMACOKINETICS, EFFICACY, AND SAFETY OF VORICONAZOLE AND ITRACONAZOLE IN HEALTHY COTTONMOUTHS (AGKISTRODON PISCIVORUS) AND MASSASAUGA RATTLESNAKES (SISTRURUS CATENATUS) WITH SNAKE FUNGAL DISEASE.
Lindemann DM; Allender MC; Rzadkowska M; Archer G; Kane L; Baitchman E; Driskell EA; Chu CT; Singh K; Hsiao SH; Sykes JM; Cox S
J Zoo Wildl Med; 2017 Sep; 48(3):757-766. PubMed ID: 28920790
[TBL] [Abstract][Full Text] [Related]
11. Voriconazole therapeutic drug monitoring in critically ill patients improves efficacy and safety of antifungal therapy.
Li H; Li M; Yan J; Gao L; Zhou L; Wang Y; Li Q; Wang J; Chen T; Wang T; Zheng J; Qiang W; Zhang Y; Shi Q
Basic Clin Pharmacol Toxicol; 2020 Dec; 127(6):495-504. PubMed ID: 32639669
[TBL] [Abstract][Full Text] [Related]
12. Voriconazole Dosing in Children Younger Than 3 Years Undergoing Cancer Chemotherapy or Hematopoietic Stem Cell Transplantation.
Yan SQ; Seyboth B; Kobos R; Eaton A; Seo SK; Cohen N
J Pediatric Infect Dis Soc; 2018 May; 7(2):169-171. PubMed ID: 28407118
[TBL] [Abstract][Full Text] [Related]
13. Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis.
Jin H; Wang T; Falcione BA; Olsen KM; Chen K; Tang H; Hui J; Zhai S
J Antimicrob Chemother; 2016 Jul; 71(7):1772-85. PubMed ID: 26968880
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of voriconazole in immunocompromised patients: systematic review and meta-analysis.
Rosanova MT; Bes D; Serrano Aguilar P; Sberna N; Lede R
Infect Dis (Lond); 2018 Jul; 50(7):489-494. PubMed ID: 29262742
[TBL] [Abstract][Full Text] [Related]
15. Using Child-Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model-based Analysis.
Wang T; Yan M; Tang D; Dong Y; Zhu L; Du Q; Sun D; Xing J; Dong Y
Pharmacotherapy; 2021 Feb; 41(2):172-183. PubMed ID: 33064889
[TBL] [Abstract][Full Text] [Related]
16. Case of mycotic cyst caused by Scedosporium apiospermum developed liver dysfunction following administration of voriconazole.
Watanabe S; Anzawa K; Mochizuki T
J Dermatol; 2017 Nov; 44(11):e296-e297. PubMed ID: 28733992
[No Abstract] [Full Text] [Related]
17. Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.
Maertens JA; Raad II; Marr KA; Patterson TF; Kontoyiannis DP; Cornely OA; Bow EJ; Rahav G; Neofytos D; Aoun M; Baddley JW; Giladi M; Heinz WJ; Herbrecht R; Hope W; Karthaus M; Lee DG; Lortholary O; Morrison VA; Oren I; Selleslag D; Shoham S; Thompson GR; Lee M; Maher RM; Schmitt-Hoffmann AH; Zeiher B; Ullmann AJ
Lancet; 2016 Feb; 387(10020):760-9. PubMed ID: 26684607
[TBL] [Abstract][Full Text] [Related]
18. Voriconazole in clinical practice.
Mikulska M; Novelli A; Aversa F; Cesaro S; de Rosa FG; Girmenia C; Micozzi A; Sanguinetti M; Viscoli C
J Chemother; 2012 Dec; 24(6):311-27. PubMed ID: 23174096
[TBL] [Abstract][Full Text] [Related]
19. Interaction between voriconazole and flucloxacillin during treatment of disseminated Scedosporium apiospermum infection.
Kennedy B; Larcombe R; Chaptini C; Gordon DL
J Antimicrob Chemother; 2015 Jul; 70(7):2171-3. PubMed ID: 25777322
[No Abstract] [Full Text] [Related]
20. Voriconazole : a review of its use in the management of invasive fungal infections.
Scott LJ; Simpson D
Drugs; 2007; 67(2):269-98. PubMed ID: 17284090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
